CYCN (Cyclerion Therapeutics, Inc. Common Stock) Stock Analysis - Politician Trades
Cyclerion Therapeutics, Inc. Common Stock (CYCN) is a publicly traded Healthcare sector company. As of May 21, 2026, CYCN trades at $3.02 with a market cap of $13.08M and a P/E ratio of -2.27. CYCN moved +4.33% today. Year to date, CYCN is +123.19%; over the trailing twelve months it is -6.21%. Its 52-week range spans $1.03 to $9.47. Rallies surfaces CYCN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded CYCN stock?
Rallies tracks politician and congressional stock disclosures for CYCN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Slate Path Capital LP sold 357.88K (~$555.11K) on Nov 21, 2024.
MCGUIRE TERRANCE sold 8 (~$27.16) on Aug 9, 2023.
MCGUIRE TERRANCE bought 92.83K (~$289.63K) on Jun 3, 2021.
CYCN Analyst Consensus
CYCN analyst coverage data. Average price target: $0.00.
Common questions about CYCN
Which politicians traded CYCN stock?
Rallies tracks politician and congressional stock disclosures for CYCN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in CYCN?
Yes. Rallies tracks politician and congressional stock disclosures for CYCN, including reported purchases, sales, dates, owners, and trade amounts when available.
Is CYCN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CYCN. It does not provide personalized investment advice.